Back to top
more

MetLife (MET)

(Real Time Quote from BATS)

$73.86 USD

73.86
881,781

+0.39 (0.53%)

Updated May 17, 2024 12:35 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (84 out of 250)

Industry: Insurance - Multi line

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Aon's Inorganic Growth Impresses, Rising Debt Level a Drag

by Zacks Equity Research

Although Aon plc's (AON) top line grows on organic strategies, continuously rising level of debt weighs on its bottom line.

    What Should You Expect From The FOMC Meet?

    by Zacks Equity Research

    What Should You Expect From The FOMC Meet?

      Mark Vickery headshot

      Awaiting the Inevitable Interest Rate Hike

      by Mark Vickery

      The Fed's slow and steady methodology has taken longer than many had anticipated to reach equilibrium, but we are definitely there now.

        MGIC Investment (MTG) Reports Robust November Business Data

        by Zacks Equity Research

        Driven by declining claim payments and improvement in new business written, MGIC Investment (MTG) posts solid figures for November and is likely to retain the momentum in the future.

          Why MetLife (MET) Could Be a Top Value Stock Pick

          by Zacks Equity Research

          MetLife (MET) is a pretty good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.

            Brown & Brown's Strategic Efforts Impress, Rising Costs Ail

            by Zacks Equity Research

            Brown & Brown's (BRO) sustained operational performance and a solid capital backup impress but rising expenses bother.

              Hartford Financial Streamlines Business With Talcott Sale

              by Zacks Equity Research

              Hartford Financial's (HIG) Talcott Resolution segment has been underperforming for quite a long time. Divestiture of this unit is expected to improve the company's overall financial health.

                Arthur J. Gallagher's Buyout to Boost Brokerage Services

                by Zacks Equity Research

                Arthur J. Gallagher (AJG) continues with its inorganic growth strategy riding on Weiss Insurance buyout.

                  Radian (RDN) Shows Potential to Grow: Apt to Buy the Stock?

                  by Zacks Equity Research

                  Radian (RDN) holds immense potential on the back of growth projections and favorable fundamentals.

                    Here's Why You Should Buy Prudential Financial (PRU) Now

                    by Zacks Equity Research

                    Prudential Financial's (PRU) compelling product portfolio plus greater scale and broader distribution capabilities position it well for long-term growth.

                      Radian Divests Clayton EuroRisk to Focus on Core Service

                      by Zacks Equity Research

                      Radian's (RDN) divestiture of Clayton EuroRisk reflects its restructuring efforts to intensify focus on core business.

                        Mark Vickery headshot

                        Top Stock Reports for Apple, Facebook & MetLife

                        by Mark Vickery

                        Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Facebook (FB) and MetLife (MET).

                          AIG Misses on Q3 Earnings Due to Weather, to Puff Up Reserves

                          by Zacks Equity Research

                          AIG's third-quarter earnings suffered from catastrophe losses, partly offset by reduction in expense.

                            MetLife (MET) Q3 Earnings Top on Volume Growth, OK's Buyback

                            by Zacks Equity Research

                            MetLife's (MET) Q3 earnings reflect volume growth. The board of directors also approves a $2 billion buyback program. The company also is on track to return $4.5 billion to shareholders in 2017.

                              Swarup Gupta headshot

                              Metlife vs. Prudential: Which is Better Ahead of Q3 Earnings?

                              by Swarup Gupta

                              With sector majors Prudential and MetLife, both scheduled to report on Nov 1, this may be a good time to consider which of these is a better stock.

                                MetLife (MET) to Report Q3 Earnings: What's in the Cards?

                                by Zacks Equity Research

                                MetLife's (MET) third-quarter earnings are likely to benefit on higher contribution from its U.S business coupled with expense management initiatives and capital management.

                                  MetLife (MET) and Units Receive Rating Action From A.M Best

                                  by Zacks Equity Research

                                  MetLife's (MET) business strategies have helped it sharpen its competitive edge and operational efficiency aided it to deliver strong results. It has received favorable ratings from several rating agencies on the back of these positives.

                                    MetLife (MET) Expands Coverage to Include Diabetic Patients

                                    by Zacks Equity Research

                                    The expansion of coverage by MetLife Hong Kong, a wholly owned subsidiary of MetLife (MET), intends to make medical facilities easily accessible for diabetic patients.

                                      MetLife's Logan Circle Buy to Boost Investment Management

                                      by Zacks Equity Research

                                      MetLife's (MET) $250 million buyout of Logan Circle primarily aims at strengthening the acquirer's investment management expertise.

                                        Why Is MetLife (MET) Down 11.5% Since the Last Earnings Report?

                                        by Zacks Equity Research

                                        MetLife (MET) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                          Insurance Stocks to Endure the Wrath of Hurricane Harvey

                                          by Zacks Equity Research

                                          Property and casualty stocks might witness an earnings drain due to hurricane Harvey, but the event is expected to benefit them in the form of increased premium prices.

                                            Forget MetLife (MET), Buy These 3 Insurance Stocks Instead

                                            by Zacks Equity Research

                                            MetLife's (MET) declining revenues from low premiums, fees and other revenues, macroeconomic factors, and low return on equity make it an unattractive stock now.

                                              The Zacks Analyst Blog Highlights: CVS Health, Marriott, Enbridge, MetLife and Aon

                                              by Zacks Equity Research

                                              The Zacks Analyst Blog Highlights: CVS Health, Marriott, Enbridge, MetLife and Aon

                                                MetLife Suffers From Declining Revenues, Spinoff Charges

                                                by Zacks Equity Research

                                                MetLife's (MET) declining revenues, low premiums, fees and other revenues continue to bother.

                                                  Mark Vickery headshot

                                                  Top Stock Reports for CVS Health, Marriott & Enbridge

                                                  by Mark Vickery

                                                  Today's Research Daily features new research reports on 16 major stocks, including CVS Health (CVS), Marriott (MAR), and Enbridge (ENB).